Cell-Based Assays Markets 2016-2024: 2018 Global Strategic Business Report - Rising Number of Drug Targets Surge Demand for Cell-Based Assays

DUBLIN, July 27, 2018 /PRNewswire/ --

The "Cell-Based Assays - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets.

This report analyzes the worldwide markets for Cell-Based Assays in US$ Million by the following Applications:

• Drug Discovery
• ADME Testing
• Basic Research

The report profiles 57 companies including many key and niche players such as:

• BD Biosciences (USA)
• Beckman Coulter, Inc. (USA)
• BioVision, Inc. (USA)
• Cisbio Bioassays (USA)
• Eurofins DiscoverX Corporation (USA)
• Merck KgaA (Germany)
• Enzo Life Sciences, Inc. (USA)
• Evotec AG (Germany)
• GE Healthcare Life Sciences (UK)
• New England Biolabs, Inc. (USA)
• PerkinElmer, Inc. (USA)
• Promega Corporation (USA)
• ProQinase GmbH (Germany)
• Qiagen NV (The Netherlands)
• Thermo Fisher Scientific, Inc. (USA)
• Xenometrix AG (Switzerland)

Key Topics Covered

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

2. INDUSTRY OVERVIEW
Global Cell-based Assays Market Witnesses Rapid Growth
Drug Discovery Leads the Cell-based Assays Application
Major Types of Cell-Based HTS Assays for Drug Screening
A Glance at Growth Drivers and Market Challenges
Growth Drivers
Market Challenges
Developed Regions Lead the Market, Developing Regions to Witness Fastest Growth
Increased Spending on Pharma R&D Spurs the Cell-based Assays Market
China and India: Hot Spots for R&D Investment
Growing Prominence of Cell-based Assays in Drug Discovery
Cell-based Assays in HTS and UHTS
Resolving Technical Limitations: Cornerstone for Future Success of Cell-based HTS
High-Content Screening (HCS) - An Expanding Technology in Cell-Based Assays
High Content Screening - Key Application Areas
HCS Market Ripe with Growth Opportunity
HCS vs. HTS
Use of Cell-based Assays in ADME-Toxicity Testing Gains Traction
Growing Inclination towards In-vitro Assays for Toxicology Studies
Hepatotoxicity Testing Occupies Largest Market Share
Cell-Based Assays Emerge as a Popular Tool in Basic Research

3. GROWTH DRIVERS AND MARKET TRENDS
Pharmaceutical Industry Leads the Way
Rising Number of Drug Targets Surge Demand for Cell-Based Assays
Rising Investment in Proteomics R&D Drive Cell-based Assays Market
Growing Focus on the Development of Reproducible and Robust Cell-based Assays
Shift towards High Throughput Research Builds Momentum for HTS
Stem Cells Exude Great Potential in Drug Toxicity Testing
Global Market for Stem Cell-Assays
Functional Assays: An Effective Way of Predicting Specific Toxic Effects
GPCR Targets to Drive Growth in Functional Cell Assay Market
Innovation in Screening Guarantees Success for Drug Discovery Programs
3D Cell Culture Technology to Put a New Spin on In Vitro Cell Analyses
Automated Multiplexing Platforms Present Growth Opportunities
Miniaturized Cell-based Assays on the Horizon
Automation of Cell-based Assays: A Growing Trend
Technology Advances in Drug Discovery Processes Spurs Cell-Based Assay Market
Development of Label-free Cell-based Assays: A Recent Trend in Biological Assays
Microfluidics Systems in Cell-based Assays
Cell-Based Assays Likely to Gain from Microfluidic Devices
Other Trends
Raman Spectroscopy: An Attractive Analytical Tool for Pharmaceutical Industry
Fluorescence Spectroscopy for Cellular Imaging Analyses
Cell-based Immunoassays: Novel Assay Technology for Autoantibodies Detection
Shift Away from Established Cell Lines to Primary Cells
Role of Cell-based Assays in Personalized Medicine: A Research Focus
Select Innovations in Cell-based Assays Market
Cell-based Assays Featuring hPBMCs for Drug Discovery and Cell Therapy Applications
Thermo Fisher Develops Innovative Tools for Aiding Cell-based Assays in Cancer Research Studies
CROs - The Targeted Customers for Cell-based Assays
Outsourcing of R&D Projects to Propel CRO Market, Driving CTMS Demand
Noteworthy Contracts of Major CROs

4. CELL-BASED ASSAYS - APPLICATION AREAS
Cell-Based Assays in Drug Discovery
Drug Target Validation
Lead Identification
Lead Optimization
Sources and Types of Cells Available for Drug Screening
Cell-Based Assays in ADME Testing
Need for Better Models: A Major Factor Driving Innovation in the Market

5. CELL-BASED ASSAYS: AN OVERVIEW
What Drives Advances in Cell-based Assays?
Cell Culture Fundamentals
An Insight into Cell Biology
Cell-based Assays: Basic Facts
Defining Cell-based Assays
Assays
Biological Assays
Quantification of Biological Activity
Cell-based Assays
Cell Based Assays: Prerequisites for Proof of Concept
List of Factors to be considered in Cell-Based Assays
Contamination with Mycoplasma: A Critical Factor
Modes of Contamination
Prevention
Uses of Cell-Based Assays
Challenges
Transient Transfection Cells
Limitations
Cell-based Assays: Product Segmentation
Assay Kits
Cell Function-Associated Assays
Cell Growth-Associated Assays
Select Methods of Evaluating Cell-Growth
Various Types of Cell Growth Associated Assays
Cell Death-Associated Assays
Lab Automation
MIACA

6. COMPETITIVE LANDSCAPE
6.1 Focus on Select Global Players
BD Biosciences (USA)
Beckman Coulter, Inc. (USA)
BioVision, Inc. (USA)
Cisbio Bioassays (USA)
Eurofins DiscoverX Corporation (USA)
Merck KgaA, (Germany)
Enzo Life Sciences, Inc. (USA)
Evotec AG (Germany)
GE Healthcare Life Sciences (UK)
New England Biolabs, Inc. (USA)
PerkinElmer, Inc. (USA)
Promega Corporation (USA)
ProQinase GmbH (Germany)
Qiagen NV (The Netherlands)
Thermo Fisher Scientific, Inc. (USA)
Xenometrix AG (Switzerland)

6.2 Recent Industry Activity
BioIVT Takes Over Ascendance Biotechnology
Agilent Acquires Luxcel Biosciences
Eurofins Acquires DiscoverX
IntelliCyt Introduces Cy-Clone Plus Assay System

7. GLOBAL MARKET PERSPECTIVE
Cell-Based Assays Market by Application

8. REGIONAL MARKET PERSPECTIVE
8.1 The United States
A. Market Analysis
Cell-Based Assay Market to Witness Significant Growth
Functional Cell Assays - A Key Segment
Increased Usage Drives Growth of Cell-based Assays
Impact of Automation & High-Throughput Screening on CBA Market
HTS Assumes Critical Importance in Drug Discovery Projects
Spending on HTS Soars in Pharmaceutical Sector
HTS Outsourcing Gathers Steam
Custom Designed Assays to Drive the US Cell-based Assay Market
Clinical Trials Market in the US
Competitive Scenario
Increased Reliance on CROs by Drug Developers Drive the Cell-based Assays Market
B. Market Analytics

8.2 Japan
A. Market Analysis
Demographics Drive Market Growth
B. Market Analytics

8.3 Europe
A. Market Analysis
Current and Future Analysis
HTS in European Pharmaceutical Sector
Innovations in Cell Culture Drive Adoption of Cell-based Assay HTS
Cell-based Assays Represent the Primary Drug Discovery Tool in HTS Laboratories
Pharmaceutical Companies Opt for Cell-Based Assays in Drug Discovery
Rising Number of Drug Targets Surge Demand for Cell-Based Assays
GPCR Targets to Drive Growth in Functional Cell Assay Market
Cell Growth-Based Assay Kits Market Makes Progress
Cell Death-Based Assays: Efficiency Improvements in Development Programs Favor Growth
Rising Cancer Incidence Propels the Need for Increased Research
Advances in Technology, Identification Methods, and Lab Disciplines in CBA Market
Regulatory Requirements in Cell-Based Assays Market
Validation Assays for Compliance with ICH Guidelines
Growth of European Drug Discovery CRO Market: Opportunities for CBA Market
Clinical Trials Market in Europe
Competitive Landscape
Clinical Trials Market in Select Regions
Spain
Garnering Investments from Multinational Pharma Companies
Russia
B. Market Analytics

8.4 Asia-Pacific
A. Market Analysis
Current and Future Analysis
Asia-Pacific Emerges as Fastest Growing Market for HTS
Asia: The Most Preferred Destination for Clinical Trials
An Overview of Clinical Trials Market in Select Countries in the Region
China
Opportunities in Expanding in the Chinese Life Sciences Sector
Growing Drug Discovery Outsourcing Market Bodes Well for Market
Pharmaceutical Outsourcing Sector in China-An Overview .
Going Ahead...
India
A Thriving Clinical Trials Market
Australia
Australia Makes Strong Pitch for Clinical Trials
Major Challenges Facing Australian Clinical Trials Market
B. Market Analytics

8.5 Rest of World
A. Market Analysis
Current and Future Analysis
Latin America: An Emerging Market for Clinical Trials
The Middle East - Brimming with Potential for Clinical Trials
Emerging Nations Capitalize on the Outsourcing Trend
B. Market Analytics

9. COMPANY PROFILES

Total Companies Profiled: 57 (including Divisions/Subsidiaries - 61)

The United States (36)
Japan (1)
Europe (22)
- France (3)
- Germany (5)
- The United Kingdom (7)
- Italy (1)
- Rest of Europe (6)
Asia-Pacific (Excluding Japan) (1)
Latin America (1)

For more information about this report visit https://www.researchandmarkets.com/research/nsnrpr/cellbased_assays?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com